INIM PHARMA AB
INIM Pharma operates as a bio-pharmaceutical company. It develops a new local treatment for severe rare lung diseases, such as idiopathic pulmonary fibrosis.
INIM PHARMA AB
Industry:
Biotechnology Pharmaceutical
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Status:
Active
Similar Organizations
MuOx Ltd.
MuOx Ltd. operates as a pharmaceutical company.
More informations about "INIM Pharma AB"
INIM Pharma AB - Crunchbase Company Profile & Funding
Organization. INIM Pharma AB . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. ... INIM Pharma operates as a bio-pharmaceutical company. It โฆSee details»
INIM Pharma AB - Företagsinformation - allabolag.se
INIM Pharma AB,559156-8471 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för INIM Pharma ABSee details»
INIM Pharma AB Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for INIM Pharma AB of Mölndal, Västra Götaland. Get the latest business insights from Dun & Bradstreet.See details»
Vicore Pharmas acquisition of INIM Pharma completed
Aug 20, 2018 Vicore Pharma Holding AB has thus acquired the shares in INIM Pharma AB. HealthCap will be the largest shareholder in Vicore Pharma Holding with 30.4% ownership โฆSee details»
INIM Pharma AB | Aktiebolag | Info & Löner - Bolagsfakta
INIM Pharma AB โ Org.nummer: 559156-8471. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m.See details»
Portfolio - HealthCap
Resistentia Pharmaceuticals AB ... (OTC) and personal care products. The Company has its own go-to-market organization in Northern Europe and in addition, select products are sold โฆSee details»
Vicore Pharma and HealthCap create a leading drug development โฆ
Jul 3, 2018 Vicore Pharma Holding AB (publ) (โVicoreโ or โThe Companyโ) has entered into an agreement to acquire INIM Pharma AB (โINIMโ), a Swedish biopharmaceutical company โฆSee details»
Vicore Pharma - Funding, Financials, Valuation & Investors
Vicore Pharma is registered under the ticker STO:VICO . Vicore Pharma is funded by 10 investors. Sanofi and Third Swedish National Pension Fund are the most recent investors. โฆSee details»
Interim report April 1 - June 30 2019 - Vicore Pharma
The acquisition of INIM Pharma in July 2018, the companyโs pipeline was ex-panded with a second drug development program, VP02. VP02 is based on a new formulation and delivery โฆSee details»
Vicore Pharmas förvärv av INIM Pharma slutfört | Tanalys
Må, aug 20, 2018 14:40 CET Styrelsen för Vicore Pharma Holding AB (publ) (ticker: VICO) kan idag meddela att förvärvet av INIM Pharma AB, vilket genomförs genom en apportemission โฆSee details»
Inim Pharma AB - Företag på Postbox 14 i undefined - Hitta.se
Inim Pharma AB är verksam inom annan naturvetenskaplig och teknisk forskning och utveckling. Bolaget är ett aktiebolag som varit aktivt sedan 2018. Leveransadress. Postbox 14 414 52 โฆSee details»
Carl-Johan Dalsgaard Appointed New CEO of Vicore Pharma
Aug 30, 2018 Carl-Johan Dalsgaard replaces Per Jansson who has been the CEO of Vicore Pharma Holding AB since 2013 and also the CEO of Vicore Pharma AB since 2007. The โฆSee details»
Vicore Pharma Holding AB (OM:VICO) completed the acquisition โฆ
Aug 20, 2018 Vicore Pharma Holding AB entered into an agreement to acquire INIM Pharma AB from Nanologica AB , Healthcap VII, L.P. a fund managed by HealthCap for approximately โฆSee details»
100 Top Health/Medical Companies in Sweden · March 2025 | F6S
Mar 1, 2025 Vicore Pharma is a Swedish biopharmaceutical company focused on the development of innovative therapies for serious lung disorders, including idiopathic pulmonary โฆSee details»
Startsidan - Pharmaxim
Vår Affärside. Vi utvecklar, distribuerar och marknadsför starka varumärken och kvalitetsprodukter som ger ökad hälsa och välbefinnande för människor och djur samtidigt som de skapar โฆSee details»
Vicore Pharma Holding AB (VICO-SE): Acquisition of INIM brings ...
Jul 4, 2018 goetzpartners securities Limited Vicore Pharma Holding AB (VICO-SE): Acquisition of INIM brings HealthCap on board 04-Jul-2018 / 11:40 GMT/BST F...See details»
Immedica Pharma AB Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Immedica Pharma AB of Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
Circius Pharma
The Scandinavian market is covered through our own organization, while distribution of our products outside of Scandinavia is handled through a comprehensive network of distributors. โฆSee details»
Home - Transient Pharma
According to the World Health Organization (WHO) three out of five people die because of chronic inflammatory diseases including diseases such as stroke, chronic respiratory diseases, heart โฆSee details»
100 Top Companies in Stockholm · March 2025 | F6S
Mar 1, 2025 Vicore Pharma is a Swedish biopharmaceutical company focused on the development of innovative therapies for serious lung disorders, including idiopathic pulmonary โฆSee details»